Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BY 4.0Cancers

Oral Cavity Cancer and the Subsequent Incidence of Other Cancer Diagnoses: A Retrospective Cohort Study in German General Practices

4 affiliations
  1. 1Department of Cariology, Periodontology, and Endodontology, Dental Clinic, Justus Liebig University Giessen, 35392 Giessen, Germany
  2. 2Department of Prosthodontics, Dental Clinic, Justus Liebig University Giessen, 35392 Giessen, Germany
  3. 3University of Marburg, University Hospital, 35043 Marburg, Germany
  4. 4Epidemiology, IQVIA, 60549 Frankfurt am Main, Germany

Abstract

Background/Objectives: Subsequent cancer diagnoses are well documented after oral cavity cancer, particularly within the upper aerodigestive tract. However, evidence from routine primary care is limited, although such data may provide complementary insights into the long-term documentation of subsequent cancer diagnoses. This study examined subsequent cancer diagnoses after oral cavity cancer in German general practices and assessed the influence of anatomically adjacent cancer codes. Methods: This retrospective cohort study used the IQVIA Disease Analyzer database. Adults with a first documented oral cavity cancer (International Classification of Diseases, 10th Revision [ICD-10]: C02–C06) recorded in German general practices between 2005 and 2024, with at least 12 months of prior observation and no earlier cancer, were included. A landmark design was applied to both cohorts: follow-up began 365 days after the index date, and individuals not observed beyond that date or with a cancer documented in the first year were excluded. Patients were matched 1:10 on age, sex, index year, consultation frequency in the 12 months before the index date and Charlson Comorbidity Index. The outcome definition was identical in both cohorts (ICD-10 C00–C97, excluding C02–C06 and C77–C80). Cox regression with robust variance estimation was used. Results: A total of 1043 patients with oral cavity cancer and 10,430 matched individuals were analyzed. A cancer diagnosis was documented in 16.8% and 6.9% of individuals, respectively, corresponding to 38.0 and 15.6 per 1000 person-years (hazard ratio [HR] 2.43; 95% confidence interval [CI] 2.06–2.87). The HR was highest among patients aged ≤60 years (HR 4.07) and lowest among those aged >70 years (HR 1.48; p for interaction <0.001). Subsequent diagnoses involving the upper aerodigestive and respiratory tracts were disproportionately represented in the oral cavity cancer cohort. Excluding anatomically adjacent cancer codes attenuated the association (HR 1.81; 95% CI 1.51–2.17). Conclusions: Oral cavity cancer was associated with a higher incidence of subsequently documented cancer diagnoses. The association was attenuated but persisted after excluding anatomically adjacent and potentially ambiguous cancer codes; the data do not establish whether these diagnoses represent confirmed second primary malignancies.

Related

  1. Incidence and predictors of mother-to-child transmission of HIV among HIV-exposed infants in public General hospitals of Tigray, Ethiopia, 2020: Retrospective cohort study
    Gebrezgiher Gebresselassie Gerezgiher, Tesfay Gebreslassie, Guesh Teklu Woldemariam +6
    PLOS OnePeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsPLOSEurope PMC
  2. Incidence of ADHD diagnoses and medication initiation among children and adolescents in Norway from 2016-2024
    Saima Orangzeb, Ingeborg Hartz, Inger Johanne Bakken +6
    European Child & Adolescent PsychiatryPeer-reviewedCC BY 4.0Full textPsychiatry & mental healthPMC
  3. Retrospective Review of Suspected Melanoma Diagnoses Made by a Single-Centre Teledermoscopy Service in New Zealand.
    Savani Kannangara, Amanda Oakley
    Dermatology practical & conceptualPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  4. Invasive Aspergillosis Complicating Severe COVID-19: Cumulative Incidence, Risk Factors, and Outcomes Between the First Wave of the Pandemic and Subsequent Waves, According to the ECMM/ISHAM Classification and a Local Case Assessment
    Marion Blaize, Charles Gibert, Dimitri Kornblum +8
    Journal of FungiPeer-reviewedCC BY 4.0Full textInfectious diseaseHAL
  5. COVID-19 among people with intellectual disability in comparison to the general population: diagnoses, hospitalizations, deaths, and vaccinations (IDcare)
    Magnus Sandberg, Jimmie Kristensson, Anna Axmon
    BMC Public HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossref
BibTeX
@article{cirkel2026oral,
  title = {{Oral Cavity Cancer and the Subsequent Incidence of Other Cancer Diagnoses: A Retrospective Cohort Study in German General Practices}},
  author = {Lisa Lotta Cirkel and Bernd Wöstmann and Karel Kostev},
  journal = {Cancers},
  year = {2026},
  month = oct,
  doi = {10.3390/cancers18213444},
  url = {https://www.mdpi.com/2072-6694/18/21/3444},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Oral Cavity Cancer and the Subsequent Incidence of Other Cancer Diagnoses: A Retrospective Cohort Study in German General Practices
AU  - Lisa Lotta Cirkel
AU  - Bernd Wöstmann
AU  - Karel Kostev
PY  - 2026
DA  - 2026/10/24
JO  - Cancers
DO  - 10.3390/cancers18213444
UR  - https://www.mdpi.com/2072-6694/18/21/3444
AB  - Background/Objectives: Subsequent cancer diagnoses are well documented after oral cavity cancer, particularly within the upper aerodigestive tract. However, evidence from routine primary care is limited, although such data may provide complementary insights into the long-term documentation of subsequent cancer diagnoses. This study examined subsequent cancer diagnoses after oral cavity cancer in German general practices and assessed the influence of anatomically adjacent cancer codes. Methods: This retrospective cohort study used the IQVIA Disease Analyzer database. Adults with a first documented oral cavity cancer (International Classification of Diseases, 10th Revision [ICD-10]: C02–C06) recorded in German general practices between 2005 and 2024, with at least 12 months of prior observation and no earlier cancer, were included. A landmark design was applied to both cohorts: follow-up began 365 days after the index date, and individuals not observed beyond that date or with a cancer documented in the first year were excluded. Patients were matched 1:10 on age, sex, index year, consultation frequency in the 12 months before the index date and Charlson Comorbidity Index. The outcome definition was identical in both cohorts (ICD-10 C00–C97, excluding C02–C06 and C77–C80). Cox regression with robust variance estimation was used. Results: A total of 1043 patients with oral cavity cancer and 10,430 matched individuals were analyzed. A cancer diagnosis was documented in 16.8% and 6.9% of individuals, respectively, corresponding to 38.0 and 15.6 per 1000 person-years (hazard ratio [HR] 2.43; 95% confidence interval [CI] 2.06–2.87). The HR was highest among patients aged ≤60 years (HR 4.07) and lowest among those aged >70 years (HR 1.48; p for interaction <0.001). Subsequent diagnoses involving the upper aerodigestive and respiratory tracts were disproportionately represented in the oral cavity cancer cohort. Excluding anatomically adjacent cancer codes attenuated the association (HR 1.81; 95% CI 1.51–2.17). Conclusions: Oral cavity cancer was associated with a higher incidence of subsequently documented cancer diagnoses. The association was attenuated but persisted after excluding anatomically adjacent and potentially ambiguous cancer codes; the data do not establish whether these diagnoses represent confirmed second primary malignancies.
SN  - 2072-6694
ER  -